TeleBehavioral Health 2026: Digital Health and AI in the Treatment of Substance Use Disorders

This talk examines the growing landscape of digital health and artificial intelligence tools available for the treatment of substance use disorders, with a focus on the clinical evidence supporting their use. Attendees will explore the efficacy data behind key tool categories — including FDA-authorized digital therapeutics, telehealth-based medication treatment, AI-driven relapse prediction, and mHealth applications. The session concludes with practical guidance on integrating these tools into clinical practice, with attention to patient selection, workflow considerations, and equity implications.